Advanced Search
Contact | Corporate | Help

Daily news email for April 04, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Biotage Unveils Isolera (TM) Spektra with Full PDA Spectral Scanning

Results of Letermovir (AIC246) Phase 2b in Prophylaxis of Human Cytomegalovirus in Recipients ...

BioRN Annual Conference 2012: Mobilizing Seed and Venture Capital for Health Innovation

Cellmid Launches Évolis (TM) Hair Products

LingVitae, Plarion and KTH Royal Institute of Technology Initiate a Collaboration to Provide ...

 BioSpace
Peregrine Pharmaceuticals, Inc. Cites Clinical Data to Highlight Potential of Bavituximab

Caffeine and Exercise: a Protective Mix Against Skin Cancer, Study

GlaxoSmithKline Cries Out Over Counterfeits

AstraZeneca PLC Hunting More Deals Like Amgen Tie-up

Bilingual Children Switch Tasks Faster Than Speakers of a Single Language, University of Toronto Study

BioSpace - Breaking News
PacificHealth Laboratories, Inc. Signs Distributor Agreement With a Leading Military Distributor

Evogene Ltd. Announces Launch of ATHLETE(TM) 4.0 Gene Discovery Computational Technology

Precision BioSciences Files Ninth Patent Infringement Lawsuit Against CELLECTIS SA Related to Engineered Meganucleases

Watson Pharmaceuticals, Inc. Confirms Favorable District Court Ruling in Generic Sanctura XR Patent Suit

Express Scripts Inc. Judge Sets Hearing on Injunction Request

Biotech News - Business Wire
ImmunoCellular Brings Second Manufacturing Site On-line

Ontario Radiology Group Installs Seven CARESTREAM DRX-1 Systems as Part of Digital Conversion

New York Genome Center Recipient of $3 Million Grant from the Alfred P. Sloan Foundation

Probiomics Limited: New Australian Drug Developer Lists on ASX

Alliance Boots Assisting in the Fight against Cancer: Roll-out of the EORTC Charitable Trust Partnership from April 2012

 Biotech News - PR Newswire
Axellus to Launch New Lactose-free Probiotic Supplement for the Whole Family in Finland

INCIVO ® (Telaprevir) in Combination With Peginterferon Alfa and Ribavirin is Cost-effective for Both Treatment-naïve and Experienced Patients With Chronic Genotype-1 Hepatitis C Virus

BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel

Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor

Waife & Associates anuncia a su nuevo socio senior en Alemania
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
US Protests India's Compulsory License for Nexavar

Nanotech Armor Guards Against Breast Cancer Remission

FDA Approves Affymax Anemia Therapy

New Guidelines on Taking Life's Measure

Bausch & Lomb to Buy Ista Pharmaceuticals

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Biscom Sets the Standard in Secure Document Delivery for Healthcare Clients; Experiences Rapid Growth by Delivering Benchmark Innovation and Customer Support

GE Healthcare Completes Acquisition of SeqWright, Inc., Expanding Capabilities in Fast Growing Molecular Diagnostic Segment

ACT Announces Approval of Bascom Palmer Eye Institute as Additional Site for Stem Cell Clinical Trial for dry Age-Related Macular Degeneration

Almac reports progress in Clinical Technologies Lean Six Sigma Efforts

MEDIAN Technologies Names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

 Clinical Trials - PR Newswire
Investigator-Sponsored Study of PLC's RenalGuard(R) Demonstrates Reduced Mortality and Fewer Adverse Events Than Alternatives

BioNeutral Group Announces Positive Results for the Ygiene 206 Sterilization Tests

U.S. Physician Groups Identify Commonly Used Tests or Procedures They Say Are Often Not Necessary

Northwestern Study Compares Endovascular Brain Aneurysm Repair Devices

Should the Science of Adolescent Brain Development Inform Public Policy

 CNN Top Stories
Opinion: Call Syria conflict a war

Texas miracle: No deaths after vicious tornado outbreak

Plane hits turbulence, several hurt

UNICEF: Millions at risk in Africa's Sahel

New World Trade Center now 100 floors
Contract Pharma
Xencor Earns Second Boehringer Milestone

UCB, Amgen Advance Sclerostin Program

Catalent, BASF in Bioavailability Alliance

Charles River, Metabolon in Biomarker Partnership

Lonza Names New CEO

 FDA Drugs- What's New
FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses

Postmarketing Requirements and Commitments: Reports

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes en la etiqueta de seguridad de los medicamentos para reducir el colesterol conocidos como estatinas

 FDA News - Business Wire
Anulex Technologies, Inc. Announces FDA Clearance for Expanded Indications of fiXate Tissue Band

GTx Submits Clinical Hold Complete Response Letter To FDA For Its Planned Phase II Clinical Study Of Capesaris® For Secondary Hormonal Therapy of Advanced Prostate Cancer

TONIX Pharmaceuticals Strengthens Management Team with the Appointments of Its New Chief Financial Officer and Senior Director of Drug Development

Dieter Bielang rejoint Sapheon en qualité de directeur des ventes internationales pour l'Europe

Aurora
FDA Press Releases
Obama administration takes action to address tobacco epidemic

U.S. Marshals seize unapproved and misbranded drug products at Missouri distributor

FDA pursues enforcement action against California fish processor

FDA to discuss risks and benefits of metal-on-metal hip replacements

FDA approves additional blood test for viruses linked to leukemia, neurologic diseases

 FDA Vaccines, Blood and Biologics - What's New
WinRho SDF Liquid

Flebogamma DIF 5%

Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

 FierceBiotech
Biogen Idec bets it can succeed on a risky PhIII ALS gamble

Billions in new venture cash targeted at early-stage biotech efforts

AstraZeneca scouts new drug deals to silence a chorus of critics

OvaScience grabs $37M B round for fertility treatments

Traditional Chinese medicine team preps for Phase II cancer study
FierceBiotech IT
Apple emerges as 'dominant' life sciences IT player

Check out the new and improved FierceBiotech IT website

Silicon Valley pro studies do-it-yourself clinical trials

NIH grabs share of Obama's new $200M bet on big data

Oracle to snap up clinical study software-maker ClearTrial

 FierceBiotech Research
Australian team produces bone stem cells, no marrow required

Check out the new and improved FierceBiotech Research website

Study: DNA sequencing dubious as disease prevention tool

Stanford CD47 breakthrough fights tumors in multiple cancers

Cadre of scientists compile volumes of data on cancer cell weaknesses

 FiercePharma
FDA battling White House over politicization of regulation

S. Korean drugmakers sue to block price cuts

Judge lets sex-bias suit against Bayer go ahead

Forest pins new hopes on Bystolic with rights buyout

Barred OTC drugmaker calls FDA oversight 'absurd'
FiercePharma Manufacturing
Novasep drawing on 40 million to fund international expansion

FDA says NuSil must get at root of contamination

FDA creates new standard for cargo theft

Ranbaxy shipping generic Lipitor from new Indian plant

Check out the new and improved FiercePharmaManufacturing website

 FierceVaccines
UPDATED: Academics' oral stomach flu vax could save lives

Study: No benefit for Merck's zoster booster

Gardasil could cut cancer in women already infected with HPV

Genetic tweaking could create chlamydia vaccine

Narcolepsy spike linked with flu shot

 Health News - BizJournals.com
Wexford Health Services wins AZ prison health care contract

Sirtris vets raise $37M for fertility startup OvaScience

U.S Preventive Service Task Force chair to speak at Wichita Medical Research annual meeting

Heritage Valley opens medical mall

Pilot program seeks to cut hospital stays
Health News - CNBC
New batch of fake Avastin reached U.S. via Britain

Eddie Lampert on CNBC: Risk 'Coming Back' to Markets

GTx sends FDA information on prostate drug

Rainwater's Son on Rainwater Foundation

Icahn demands that Amylin extend nominating period

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Carl Icahn Takes Aim at Amylin Board, After BMS' Acquisition Offer

OvaScience Scores $37M in Series B Financing to Advance Fertility Treatment

New York Genome Center Gets $3M from Sloan Foundation

Novartis Looks to Turkey for Emerging Markets HQ

New York Genome Center Gets $3M from the Sloan Foundation
Marketwire - Pharma and Biotech
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360° Boston', June 27-29, 2012

Open-Source Drug Research Consortium Draws a Major New Champion

Evogene Announces Launch of ATHLETE(TM) 4.0 Gene Discovery Computational Technology

Insception Cord Blood Program Launches New iPregnancy Checklist App

Functional Technologies Signs LOI to Divest Non-Core Assets, Cut Non-Essential Spending

 MassBio News
Norton High School Named MassBioEd Innovative School of the Year

Vertex Founder Joshua Boger to Receive MassBio's Henri Termeer Innovative Leadership Award

MassBio Launches New Blog: MassBioHQ

What has made Massachusetts a better place for biotech Make your nomination by 5 PM on Feb. 24th!

What has made Massachusetts a better place for biotech Make your nomination by Feb. 24th!

 Medical Pharma - PR Newswire
WebChartMD, Pacific Medical Centers Complete Partial Dictation Interface to EHR

La Asociación Latinoamericana de Sistemas Privados de Salud (ALAMI) busca mejorar prácticas de salud privada

Infertility: Debilitating Disease or Extraordinary Opportunity

MD+DI, the Global MedTech Industry Authority, in Partnership with Medsider.com Announce the Launch of a Complimentary Podcast Series Featuring Interviews with C-level Executives

Medbox, Inc. Supports Increased Regulation on the California Medical Marijuana Industry
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
Know before you go

Confronting the Gordian knot

Agbiotech 2.0

Tiptoeing around transgenics

Mission Therapeutics

 New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge
New York Times- Pharmaceuticals
Americans Struggle With Medical Care Despite Economic Recovery

F.T.C. Approves Merger of Express Scripts and Medco

Panel Recommends More Testing for Obesity Drugs

The Place to Head Off Malaria

Judge Bars Imported Drugs in Executions

 OnBioVC
1Q12 White Paper | A is for Innovation And

Promedior, Inc.: Series D $21.5M

Collegium Pharmaceutical, Inc.: Series B $22.5M

BioAmber, Inc.: Series C $30M

LanzaTech, Ltd.: $55.8M Series C

 Outsourcing-Pharma
Comparator sourcing is a complex challenge in a globalised market says Clinigen

Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing

European CMO market will double in just 6 years, says Frost & Sullivan

Social network sites is key to trial recruitment success, says expert

Social network sites key to trial recruitment success, says expert
Pharma News - Business Wire
Medivir Announces Acceptance of Four TMC435 Abstracts for Presentation at the EASL meeting

Bristol-Myers Squibb to Present New Data Demonstrating Company's Commitment to Research and Development in Liver Disease at The International Liver CongressTM / European Association for the Study of the Liver (EASL) Annual Meeting

Orexo: Invitation Capital Markets Day May 3, 2012

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 25, 2012

Samenvatting: Joseph F. Woody en Lisa N. Colleran treden toe tot raad van bestuur van moedermaatschappij van KCI en LifeCell

 Pharma News - PharmiWeb
PREMIER Biosoft Awarded for its Exemplary Contribution Towards Corporate Social Responsibility

Inspra®(eplerenone) now Approved for Reduction of Risk for Cardiovascular Morbidity and Mortality in Adult Patients with Chronic Heart Failure (NYHA Class II) and LVEF

Inspra®(eplerenone) now Approved for Reduction of Risk for Cardiovascular Morbidity and Mortality in Adult Patients with Chronic Heart Failure (NYHA Class II) and LVEF

Hospitality Industry Veteran Tina Stehle Leaves Agilysys

World Health Day 2012 - Good health adds life to years

 Pharma News - PR Newswire
Abbott to Present Positive Phase 2 Results from Multiple Interferon-Free Studies of Combination Regimens for the Treatment of Hepatitis C

Assured Pharmacy Reports Results for the Fiscal Year 2011

Fortune 100 Companies Turning to CoreBrand for Its Expertise in Crisis Brand Management

Xencor Receives Second Milestone Payment from Boehringer Ingelheim Under Antibody Technology License Agreement

Icahn Issues Open Letter to the Board of Directors of Amylin Pharmaceuticals
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

 PRWeb - Biotechnology
Enhanced Biomarker Test Aids Clinicians With Difficult to Treat...

Almstead Transforms Manhattan's Streets, Rooftops, Backyards and...

Doctor Evidence, LLC Announces Third Consecutive Year of Growth Above...

The Stunning Sequel to the Bestselling Technothriller of 2011, WIRED,...

Hellas Sports Construction Introduces Eco-Friendly AkzoNobel System to...
PRWeb - Pharmaceuticals
Cutting-Edge Online Resource Prepares Students in Pharmacy Technician...

Michael W. Miller Warns of Link Between Teenage Depression, Drug Use

If It's on Amazon, It Must Be Amazing: Liberty Health Network...

Chemical Management System Helps Companies Create Audit-Ready Plants

Massachusetts Plaintiff Personal Injury Law Firm Thornton & Naumes...

 Scientific American
Infectious Selflessness: How an Ant Colony Becomes a Social Immune System

'Breathtaking' Mummy Coffin Covers Seized in Israel

Why 'Uncanny Valley' Human Look-Alikes Put Us on Edge

New Images of Titanic Wreck Revealed

How Useful Is Whole Genome Sequencing to Predict Disease

 Sports - ESPN Basketball
Champion Wildcats return home to adoring fans

Syracuse, SDSU slated for Battle on Midway tilt

Washington's Wroten declares for NBA draft

Weber State guard Lillard headed to NBA draft

Docs amputate foot of man shot in Lexington
Sports News - ESPN
Petrino back at Razorbacks practice after crash

Impact spring newcomers for 2012

Petrino cleared to watch Razorbacks practice

Arkansas gov.: Petrino 'upbeat' after accident

Ducks sophomore RB Carson plans to transfer

 Xconomy Life Sciences
See You Today at New England's Emerging Biotech Stars***SOLD OUT***

See You Today at New England's Emerging Biotech Stars: Just 8 Tickets Left

OvaScience Adds $37M for Fertility Treatments

Boston Deals: Funding for FRX, Allocure, Good Start, & FirstBest

See You This Afternoon at Reinventing Biotech's Business Model

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012